303 related articles for article (PubMed ID: 29956751)
1. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
[TBL] [Abstract][Full Text] [Related]
2. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways.
Wei J; Wang R; Lu Y; He S; Ding Y
Eur J Pharmacol; 2022 Feb; 916():174631. PubMed ID: 34774850
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
4. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
Liu Y; Bunston C; Hodson N; Resaul J; Sun PH; Cai S; Chen G; Gu Y; Satherley LK; Bosanquet DC; Al-Sarireh B; Tian X; Hao C; Jiang WG; Ye L
Int J Oncol; 2017 May; 50(5):1491-1500. PubMed ID: 28393239
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
7. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
8. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.
Liu J; Zhao Z; Sun Z; Liu C; Cheng X; Ruge F; Yang Y; Jiang WG; Ye L
Oncol Rep; 2020 Feb; 43(2):562-570. PubMed ID: 31894335
[TBL] [Abstract][Full Text] [Related]
10. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
[TBL] [Abstract][Full Text] [Related]
11. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer.
Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
[TBL] [Abstract][Full Text] [Related]
15. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
[TBL] [Abstract][Full Text] [Related]
17. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
19. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
